Sector News

Sanofi opens new HQ

October 14, 2019
Life sciences

Sanofi has opened a new UK Headquarters, based at Thames Valley Park in Reading, Berkshire.

The company welcomed Matt Hancock, secretary of state for health and social care, to open the “state of the art” facility, along side Paul Hudson, chief executive officer of Sanofi and Hugo Fry, UK’s managing director.

The new 70,000 square ft. office facility marks a £37 million investment to Reading and will be the new base for 500 of the 1,200 employees in the UK.

“We are delighted to unveil our new headquarters and it has been an honour to welcome the Rt Hon Matt Hancock, secretary of state for health and social care, to today’s event,” says Hugo Fry, managing director at Sanofi in the UK.

He continued, “Thames Valley Park is well located and connected, but also home to global technology leaders and one of the best places for life sciences in the world. Just as delivering the best outcomes for the one million UK patients we support every month is important to us, we paid particular attention to designing a space that promotes the health and wellbeing of our employees.”

The company revealed that it is actively seeking to recruit at least 50 new roles in the coming months, in addition to ten graduate students via its new Aspiring Leaders programme.

By Anna Smith

Source: Pharma Times

comments closed

Related News

November 28, 2021

Founder-led biotech is making space for ideas—and diverse leaders—where it didn’t exist before

Life sciences

Decades ago, the founder-led biotech was rare and considered the tougher path to follow. Now there is a trend of founder-led biotechs that have risen in prominence in recent years, going from startup to well known with lightning speed. Scientists-turned C-suite occupants know their technology inside out. They’ve got credibility both at the bench working with their research teams and in the boardrooms selling their future products.

November 28, 2021

Pfizer to become $100B behemoth next year thanks to COVID-19 drug and vaccine: analyst

Life sciences

Pfizer’s revenue could reach $101.3 billion in 2022, with major contributions coming from the company’s BioNTech-partnered COVID vaccine and an antiviral therapeutic that has shown stellar clinical data, SVB Leerink analyst Geoffrey Porges projected in a Monday note to clients.

November 28, 2021

GlaxoSmithKline takes aim at sick pay access inequities with microgrant program and new campaign

Life sciences

In a survey commissioned by GlaxoSmithKline’s consumer health division of 2,000 working people in the U.S., almost 70% admitted to clocking in while sick, often because they couldn’t afford to lose a day’s pay. Black and Latina women were 10% more likely than white women to shun taking sick time for fear of fallout from their boss, according to the company’s 2021 Temperature Check Report.

Send this to a friend